Fresenius | FRE - Current Liabilities


Fresenius reported EUR8.38B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Akzo Nobel EUR 4.39B 180M Mar/2026
Alcon AG USD 3B 45M Mar/2026
AstraZeneca USD 32.57B 1.95B Mar/2026
BASF EUR 16.41B 838M Dec/2025
Bayer EUR 33.46B 875M Mar/2026
Beiersdorf EUR 3.51B 261M Dec/2025
DaVita Healthcare Partners USD 2.87B 274.18M Mar/2026
Demant DKK 7.42B 1.63B Dec/2025
E.ON EUR 29.49B 1.4B Mar/2026
Essilor EUR 12.15B 766M Dec/2025
Fresenius EUR 8.38B 1.18B Dec/2025
Fresenius Medical Care EUR 6.73B 484.42M Mar/2026
Getinge SEK 15.05B 169M Dec/2024
Givaudan CHF 2.35B 422M Dec/2025
GlaxoSmithKline GBP 22.43B 1.04B Mar/2026
GN Store Nord DKK 4.81B 2.5B Mar/2026
GRIFOLS EUR 2.12B 105M Mar/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Lonza CHF 3.57B 421M Dec/2025
Merck EUR 9.35B 307M Mar/2026
Novartis USD 31.37B 4.1B Mar/2026
Philips EUR 7.43B 78M Mar/2026
Roche Holding CHF 28B 421M Dec/2025
RWE EUR 36.24B 13.31B Mar/2026
Sanofi EUR 30.01B 1.66B Mar/2026
Smith & Nephew USD 1.54B 236M Dec/2025